News Daily News Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX Michael O'Riordan January 15, 2026
News Conference News AHA 2025 CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI Michael O'Riordan November 11, 2025
News Conference News TCT 2025 Concerto in the Cath Lab: Music Benefits Heart Health After PCI Michael O'Riordan October 25, 2025
News Daily News Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS Todd Neale October 03, 2025
News Daily News Nonatherosclerotic Causes of MI Common in Younger Patients L.A. McKeown September 17, 2025
News Daily News Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza Todd Neale July 25, 2025
News Daily News Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board Michael O'Riordan June 25, 2025
News Daily News Troponin Spikes After Exercise Not Linked to CAD in Middle-aged Athletes Michael O'Riordan June 20, 2025
News Daily News Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA Yael L. Maxwell May 15, 2025
News Conference News ACC 2025 AI Shows Promise in Detecting Type 1 MI and Need for Revascularization Yael L. Maxwell April 07, 2025
News Daily News Inconsistent Troponin Testing in US EDs Warrants Closer Look Todd Neale January 28, 2025
News Daily News High-Sensitivity Troponin Assays Not All the Same, APACE Data Confirm Caitlin E. Cox January 27, 2025
News Conference News HFSA 2024 Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM L.A. McKeown October 04, 2024
News Daily News New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery Michael O'Riordan September 24, 2024
News Conference News ESC 2024 AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions Caitlin E. Cox September 12, 2024
News Daily News Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs L.A. McKeown August 15, 2024
News Daily News CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI Yael L. Maxwell July 18, 2024
News Industry News CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction May 29, 2024